Obermatt
See Similar Stocks →

Ambarella

NSQ:AMBA · KYG037AX1015
Semiconductors & Semiconductor EquipmentMedium

360

19
EV / EBIT3
Price / Owner Earnings81
Owner Earnings Yield1
Dividend Yield1
Price/Sales56
EV / Gross Profit52
Price/Book41
Return on Capital9
Cash Return on Capital13
Return on Equity19
EBIT Margin10
Gross Profitability75
Accruals62
Owner Earnings Margin11
Sales growth69
Profit growth79
Reinvestment29
Price momentum44
Debt load80
Refinancing47
Debt Payback1
Liquidity6
Analyst ratings12
Opinion Changes37
Price Target Upside94
Market mood22
Value Creation10/20creating some value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Ambarella clears its cost of capital, but the record is mixed across the five tests. Real value creation, just not yet consistent.

Profile

CountryUSA
IndustrySemiconductors & Semiconductor Equipment
SizeMedium
TypePublic Company
ExchangeNASDAQGS
Founded2004
Employees495
Websiteambarella.com
ISINKYG037AX1015
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)
Themes
Image RecognitionMachine LearningAutonomous VehiclesSensorsComputer VisionFacial RecognitionIndustrial AutomationDetectors, Sensors and MemsEdge ComputingArtificial IntelligenceBroadcastingSecuritySemiconductor

Description

Ambarella, Inc. (Ambarella) develops low-power system-on-a-chip, or SoC, semiconductors and software for edge and physical artificial intelligence (AI) applications and intelligent automation. The company’s technologies make electronic systems smart…

Analysis

Weak and unloved

Ambarella, Inc. scores below average on quality and is priced accordingly, a low-conviction position in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is adequate. The company scores 10/20 on our value-creation score: creating some value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
8
2023202420252026

All-time high

61

Jan 2023

All-time low

1

Jan 2024

Average rank

22

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
56
10
13
9
Price/Earnings
1
37
37
3
Price/Book
41
23
36
26
Dividend Yield
1
1
1
1
Value (overall)
7
13
15
7

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Ambarella with its peers
eXoZymes
NAQ:EXOZ
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Quest Diagnostics
NYQ:DGX
35
CountryUSA
IndustryHealth Care Providers & Services
SizeX-Large
Full Stock Analysis →
Personalis
NMQ:PSNL
8
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Tango Therapeutics
NMQ:TNGX
16
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Pacific Biosciences of California
NSQ:PACB
16
CountryUSA
IndustryLife Sciences Tools & Services
SizeSmall
Full Stock Analysis →
Aura Biosciences
NMQ:AURA
—
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →